T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 51–68 of 68 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02086591	A Phase II Study of Doxycycline in Relapsed NHL	terminated	Phase 2	7	University of RochesterOTHER	1	Dec 22, 2016	clinicaltrials
NCT00278265	Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia	terminated	Phase 2	12	German CLL Study GroupOTHER	1	Oct 3, 2016	clinicaltrials
NCT02808091